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We defined the epitopes recognized by three influenza A virus-specific, H-2Kd-restricted CD81 cytotoxic
T-lymphocyte (CTL) clones: H1-specific clone A-12, H2-specific clone F-4, and H1- and H2-cross-reactive clone
B7-B7. The A-12 and B7-B7 clones recognized the same peptide, which comprises amino acids 533 to 541
(IYSTVASSL) of A/PR/8 hemagglutinin (HA). The F-4 and B7-B7 clones both recognized the peptide which
comprise amino acids 529 to 537 (IYATVAGSL) of A/Jap HA. Amino acids 533 to 541 of A/PR/8 HA are
compatible with amino acids 529 to 537 of A/Jap HA. Amino acid S at positions 3 and 7 was responsible for
recognition by H1-specific clone A-12, while amino acid G at position 7 was responsible for recognition by
H2-specific clone F-4. Two conserved amino acids, T at position 4 and A at position 6, were responsible for
recognition by H1-, and H2-cross-reactive clone B7-B7. These results indicate that a single nine-amino-acid
region is recognized by HA-specific CTL clones of three different subtype specificities and that the amino acids
responsible for the recognition by the CTL clones are different.
Infection with influenza A virus induces influenza A virus-
specific CD81 cytotoxic T lymphocytes (CTLs) (5). It is gen-
erally accepted that influenza A virus-specific CD81 CTLs play
an important role in recovery from influenza virus infection
because they clear virus-infected cells from infected mice (8,
9). CTLs recognizing hemagglutinin (HA) are either subtype
specific or subtype cross-reactive for H1, H2, and H3. We
previously reported that H1- and H2-cross-reactive CTL clone
B7-B7 was induced by stimulation with a hybrid protein which
contained a portion of the NS1 subunit and the HA2 subunit of
the A/PR/8 virus (1, 4) and that the epitope recognized by this
CTL clone at amino acids (aa) 533 to 543 in the transmem-
brane region of HA (4).
In the present paper, we report H-2Kd-restricted, H1-specific
and H2-specific CD81 CTL clones. The epitopes recognized by
these two CTL clones were determined to be in the same
region on HA and also in the same region as that recognized
by H-2Kd-restricted, H1- and H2-cross-reactive CD81 CTL
clone B7-B7. We then define the amino acids on the epitope
which are responsible for recognition by the CTL clones with
respective specificity or cross-reactivity.
Male BALB/c mice were purchased from Charles River
Breeding Laboratories (Wilmington, Mass.) and used at 4 to 5
weeks of age. Influenza A viruses A/PR/8 (A/Puerto Rico/8/34,
H1N1), A/Jap (A/Japan/305/57, H2N2), and A/PC (A/Port
Chalmers/1/73, H3N2) were propagated in 9-day-old embryo-
nated chicken eggs. P815 cells (H-2d, mastocytoma), CV-1
cells, and CVK-10 (H-2Kd-transfected CV-1 cell line) cells,
kindly provided by T. J. Braciale, were used as target cells.
Peptides were prepared by the solid-phase method on an
ABI 430A peptide synthesizer (Applied Biosystems, Inc., Fos-
ter City, Calif.) as previously described (2). For the amino acid
sequences of these peptides, see Table 2. Mice were immu-
nized intranasally with 100 PFU of the virus under methoxy-
flurane anesthesia as previously reported (1). Spleens of mice
immunized with A/PR/8 or A/Jap were removed 3 or more
weeks after immunization for in vitro stimulation.
Establishment and characterization of CTL clone B7-B7
were previously reported (2–4). The A-12 and F-4 CTL clones
were established in the same way with a minor modification.
Limiting dilution was carried out to establish CTL clones. The
A-12 and F-4 clones described in this paper grew in wells in
which two and four responder cells had been seeded, respec-
tively. CTL assays were performed as previously reported (3).
Specific lysis was calculated by the formula 100 3 [(release by
CTL 2 spontaneous release)/(maximum release 2 spontane-
ous release)]. CTL clones were stained with fluorescein iso-
thiocyanate-conjugated anti-L3T4 (CD4) or phycoerythrin-
conjugated anti-Lyt2 (CD8) antibodies.
We established two CTL clones (A-12 and F-4) from spleen
cells of BALB/c mice immunized with the A/PR/8 or A/Jap
virus. CTL clone A-12 lysed A/PR/8 (H1N1)-infected P815
target cells but did not lyse A/Jap (H2N2) or A/PC (H3N2)
virus-infected P815 cells (data not shown). CTL clone F-4 lysed
A/Jap-infected P815 cells but did not lyse A/PR/8 or A/PC
virus-infected P815 cells (data not shown). CTL clone B7-B7
lysed P815 cells infected with the A/PR/8 or A/Jap virus. Thus,
clone A-12 is H1 subtype specific, clone F-4 is H2 subtype
specific, and clone B7-B7 is cross-reactive for H1 and H2 (2–4).
Clones A-12, F-4, and B7-B7 had a CD81 CD42 phenotype.
L929 cells (H-2k) transfected with genes coding for H-2Dd
(DM1 cells) and H-2Ld (LM1 cells) and CV-1 and CVK-10
* Corresponding author. Mailing address: Center for Infectious Dis-
ease and Vaccine Research, University of Massachusetts Medical Cen-
ter, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508) 856-
4182. Fax: (508) 856-4890. E-mail: francis.ennis@banyan.ummed.edu.
† Present address: Department of Otolaryngology, Osaka University
Medical School, Osaka, Japan.
‡ Present address: Department of Bacteriology, Kurume University
School of Medicine, Kurume, Japan.
§ Present address: Department of Virology 1, National Institute of














cells (CV-1 cell line transfected with genes coding for H-2Kd
cells) were used to examine major histocompatibility complex
restriction. Clone A-12 lysed A/PR/8 virus-infected P815 and
infected CVK-10 cells; however, it did not lyse A/PR/8 virus-
infected DM1 cells, infected LM1 cells, infected L929 cells, or
infected CV-1 cells (Table 1). Clone F-4 lysed A/Jap virus-
infected P815 and CVK-10 cells but did not lyse A/Jap virus-
infected DM1, LM1, L929, or CV-1 cells. Clone B7-B7 lysed
P815 and CVK-10 cells infected with the A/PR/8 or A/Jap virus
(Table 1). These results indicate that the recognition of the
target cells by these three CTL clones was restricted by the
H-2Kd allele.
We previously reported that an H1- and H2-cross-reactive
CTL epitope is located within the transmembrane region (aa
533 to 543) of HA (7). We found that aa 533 to 543 of A/PR/8
HA are comparable to aa 529 to 539 of A/Jap HA and that
there are three amino acid substitutions within this region
(Table 2). In the present paper, amino acid residues are num-
bered based on the amino acid sequence of A/Jap HA.
Clones A-12 and F-4, respectively, recognized aa 533 to 543
of A/PR/8 HA and aa 529 to 537 of A/Jap HA (data not
shown). We synthesized peptides with an A-S substitution at
position 531, a G-S substitution at position 535, and an S-V
substitution at position 538 or a peptide with two amino acid
substitutions (Table 2). Clone A-12 lysed P815 cells pulsed
with peptides f2, f3, f5, f6, f7, and f8 but did not lyse target cells
pulsed with peptide f1 or f4 (Fig. 1). Clone F-4 lysed P815 cells
pulsed with f1, f2, f4, and f6 but not cells pulsed with f3, f5, f7,
or f8 (Fig. 1). The results were similar at peptide concentra-
tions of 100, 10, 1, and 0.1 mg/ml (data not shown). These
results indicate that S residues at the positions 531 and 535 are
essential for recognition by clone A-12, while the G at position
535 is essential for recognition by clone F-4.
Clone B7-B7 lysed P815 cells pulsed with each of the eight
peptides (f1 through f8) (Fig. 2). We then synthesized another
FIG. 1. P815 cells were pulsed with each of peptides f1 to f8 at 10 mg/ml and
used as target cells for H1-specific CTL clone A-12, H2-specific CTL clone F-4,
and the H1- and H2-cross-reactive CTL clone B7-B7 in 4-h CTL assays. The
effector-to-target cell ratios were 8:1 for the A-12 clone, 6:1 for the F-4 clone,
and 7:1 for the B7-B7 clone.
TABLE 1. Influenza A virus subtype specificities and H-2Kd
restriction of CTL clones





P815 A/PR/8 37.7 26.6 66.1
A/Jap 6.7 56.4 72.1
None 5.9 14.5 25.2
Ld-L929 (H-2Ld) A/PR/8 1.1 1.7 2.4
A/Jap 24.2 21.7 2.1
None 1.8 1.8 1.3
Dd-L929 (H-2Dd) A/PR/8 1.4 6.3 0.6
A/Jap 22.5 20.6 20.3
None 28.6 0.4 22.5
L929 A/PR/8 20.6 0.9 21.0
A/Jap 22.4 24.4 14.7
None 24.1 23.0 15.6
Expt 2
CV-K10 (H-2Kd) A/PR/8 37.5 20.1 31.8
A/Jap 6.4 28.1 34.9
None 2.3 0.8 1.8
CV1 A/PR/8 20.7 20.5 21.1
A/Jap 3.6 2.5 20.5
None 21.8 21.7 20.4
a The effector-to-target cell ratio was 5:1 in a 4-h assay.
TABLE 2. Amino acid sequences of the peptides used in
the experiments
Peptide Amino acid sequencea
f1 (A/Jap)...........................................529I Y A T V A G S L S L539
f2 ......................................................... – – S – – – G – – S –
f3 ......................................................... – – A – – – S – – S –
f4 ......................................................... – – A – – – G – – V –
f5 ......................................................... – – S – – – S – – S –
f6 ......................................................... – – S – – – G – – V –
f7 ......................................................... – – A – – – S – – V –
f8 (A/PR/8) ........................................ – – S – – – S – – V –
g1 (A/Jap) ..........................................529I Y A T V A G S L537
g2......................................................... A – – – – – – – –
g3......................................................... – A – – – – – – –
g4......................................................... – – – A – – – – –
g5......................................................... – – – – A – – – –
g6......................................................... – – – – – S – – –
g7......................................................... – – – – – – – A –
g8......................................................... – – – – – – – – A
g9 (A/PR/8) ....................................... – – S – – – S – –
h1 ........................................................ – – – A A – – – –
h2 ........................................................ – – – – A S – – –
h3 ........................................................ – – – A – S – – –
a The residues are numbered based on the amino acid sequence of A/Jap HA.
Dashes represent identical amino acids.













set of peptides (Table 2). In this 9-mer region, there were
seven amino acids (IY-TVA-SL) conserved between A/PR/8
and A/Jap. Each amino acid was replaced with A, except the
amino acid residue at position 6, which was replaced with S.
Clone B7-B7 did not lyse P815 cells pulsed with peptide g3 at
a concentration of 10 mg/ml and peptide g8 at a concentration
of 1 mg/ml but did lyse those pulsed with other peptides at
concentrations of 10, 1, and 0.1 mg/ml (Fig. 2). It has been
suggested that Y at position 2 and L at position 9 are anchor
residues; therefore, it is likely that peptides g3 and g9 did not
bind to H-2Kd.
We next synthesized three other peptides which have A and
S substitutions at two of positions 4, 5, and 6 (Table 2). Clone
B7-B7 lysed P815 cells pulsed with peptide h1 or h2 at con-
centrations of 10, 1, and 0.1 mg/ml (Fig. 2). Clone B7-B7 did
not lyse target cells pulsed with peptide h3. However, P815
cells pulsed with peptide h3 were lysed by the A-12 clone (data
not shown). These results indicate that amino acids at positions
4 and 6 are essential for recognition by clone B7-B7.
We have defined the epitopes recognized by three influenza
A virus-specific, H-2Kd-restricted CD81 CTL clones, A-12,
F-4, and B7-B7, in the present paper. Clones A-12 and B7-B7
recognized the same peptide region, which comprises aa 533 to
541 of A/PR/8 HA. H2-specific clone F-4 and clone B7-B7 both
recognized the peptide which comprised aa 529 to 537 of A/Jap
HA. We found that aa 533 to 541 of A/PR/8 HA are compat-
ible with aa 529 to 537 of A/Jap HA. Therefore, one compat-
ible region of HA was recognized by HA-specific CTL clones
of three different subtype specificities.
Amino acid residues responsible for recognition by CTLs
were defined. Clone A-12 recognized the peptides which had S
at either position 3 or 7 but not those which have A at position
3 and G at position 7. On the other hand, F-4 recognized
peptides which had a G at position 7 but not those which have
an S at that position. Thus, the amino acids at positions 3 and
7 were important for recognition by clone A-12, and the amino
acid at position 7 was important for recognition by clone F-4.
Amino acids at positions 4 and 6 were essential for recognition
by clone B7-B7.
The results in the present paper, along with those reported
in our previous papers (6, 10), suggest that the virus specificity
of T lymphocytes is not determined solely by the degree of
amino acid conservation in the epitopes among viruses. It is
likely that the degree of T-cell receptor (TCR) stringency on T
lymphocytes is also responsible for virus specificity or virus
cross-reactivity. It will be interesting to analyze the TCR of
these T-cell clones to further determine the interactions be-
tween TCR and peptides. The results indicate that recognition
of a single peptide by T lymphocytes is heterogeneous and
provide an interesting model for understanding T-lymphocyte
recognition of epitopes.
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FIG. 2. P815 cells were pulsed with each of peptides g1 to g8 and h1 to h3 at
various concentrations and used as target cells for H1- and H2-cross-reactive
CTL clone B7-B7 in a 4-h CTL assay. The effector-to-target cell ratio was 7:1
when peptides g1 to g8 were used and 4:1 when peptides h1 to h3 were used.
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